文献速递肾癌与肾肿瘤

机器人手术普及与小肾mass过度治疗的时间关联

The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.
PubMed 文献 · J Urol · 2018-05-22

该研究基于NCDB数据库2010至2014年52,804例≤4cm小肾mass患者,发现手术仍是主要治疗方式(2010年75.0%、2014年74.2%),主动监测仅从4.8%升至6.0%,而机器人肾手术从22.1%升至39.7%,机器人部分和根治性肾切除术的增幅(分别为82.0%和63.0%)远大于主动监测(25.0%),提示机器人技术扩散可能推动过度治疗。

要点

  • 小肾mass手术占比居高不下,2014年仍达74.2%。
  • 机器人肾手术2010至2014年从22.1%升至39.7%。
  • 机器人手术增幅远超主动监测,老年及合并症者亦然。

核心结论

  • 机器人手术切除的采用速度超过了小肾mass主动监测的推广,提示机器人技术扩散可能助长过度治疗,尤其在老年和合并症患者中。

研究设计与样本

  • 基于NCDB的回顾性队列研究,纳入2010至2014年诊断的52,804例≤4cm小肾mass患者,比较主动监测、消融及机器人、腹腔镜和开放手术的使用趋势,并用多因素logistic回归分析相关因素。

主要发现

  • 手术在所有研究年份均为主要治疗方式,2010年和2014年分别占75.0%和74.2%。
  • 主动监测从2010年4.8%升至2014年6.0%(p<0.001),机器人肾手术从22.1%升至39.7%(p<0.001)。
  • 机器人部分和根治性肾切除术的增幅分别为82.0%和63.0%,大于主动监测的25.0%。
  • 在≥75岁或Charlson指数≥2的亚组中,机器人手术相对主动监测的增幅同样更明显。
  • 多因素分析中,2014年 vs 2010年诊断与机器人肾手术相对主动监测(OR 1.44,95%CI 1.20-1.72,p<0.001)及非机器人手术干预(OR 2.59,95%CI 2.30-2.93,p<0.001)的增加相关。

临床怎么用

  • 面对小肾mass患者,尤其是老年或合并症较多者,应充分评估主动监测的适用性,避免默认选择机器人手术。
  • 机器人技术可及性提高时,需警惕技术驱动而非病情驱动的治疗升级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated contemporary practice patterns in the management of small renal masses. MATERIALS AND METHODS: We identified 52,804 patients in the NCDB (National Cancer Database) who were diagnosed with a small renal mass (4 cm or less) between 2010 and 2014. Utilization trends of active surveillance, ablation and robotic, laparoscopic and open surgical techniques were compared among all comers, elderly patients 75 years old or older and individuals with competing health risks, defined as a Charlson index of 2 or greater. Multivariable logistic regression models were used to assess factors associated with robotic renal surgery and active surveillance. RESULTS: Surgery remained the primary treatment modality across all years studied, performed in 75.0% and 74.2% of cases in 2010 and 2014, respectively. Although increases in active surveillance from 4.8% in 2010 to 6.0% in 2014 (p <0.001) and robotic renal surgery (22.1% in 2010 to 39.7% in 2014, p <0.001) were observed, the increase in the proportion of small renal masses treated with robotic partial and radical nephrectomy was greater than that of active surveillance (82.0% and 63.0%, respectively, vs 25.0%). Subgroup analyses in individuals 75 years old or older, or with a Charlson index of 2 or greater likewise revealed preferential increases in robotic surgery vs active surveillance. On multivariable analysis later year of diagnosis was associated with increased performance of robotic renal surgery compared to active surveillance (2014 vs 2010 OR 1.44, 95% CI 1.20-1.72, p <0.001) and nonrobotic procedural interventions (2014 vs 2010 OR 2.59, 95% CI 2.30-2.93, p <0.001). CONCLUSIONS: Robotic surgical extirpation has outpaced the adoption of active surveillance of small renal masses. This raises concern that the diffusion of robotic technology propagates overtreatment, particularly among elderly and comorbid individuals.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Shah PH, Alom MA, Leibovich BC, et al. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018. PMID: 29792881. doi:10.1016/j.juro.2018.05.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。